The Route to Market as an Ownership Asset

A product does not have a business until it has a route to market. Health companies often spend years developing products, evidence, technology or intellectual property and still treat distribution as a final execution problem. We think that reverses the logic. The route through which a company reaches customers can shape margins, data, bargaining power, speed, brand control and even the type of company that can be built. In some situations, the route to market can become one of the most valuable assets in the business. For KØDE, that makes distribution an ownership question. DISTRIBUTION IS NOT A SALES CHANNEL A sales channel is a way to transact. A route to market is the wider system through which demand becomes revenue. It includes questions such as: Who controls access to the customer? Who creates demand? Who carries the relationship? Who owns the customer data? Who sets pricing? Who provides trust? Who handles education? Who captures the margin? Who can introduce the next product? The answer may involve retail, pharmacies, healthcare professionals, distributors, digital channels, employers, marketplaces, specialist communities or physical locations. The important point is that no channel is neutral. Every route creates a different economic architecture. RENTED ACCESS AND OWNED ACCESS ARE DIFFERENT Many companies appear to have distribution when they actually have temporary access. They depend on paid acquisition. A powerful marketplace. One national distributor. One major retailer. One platform algorithm. One procurement relationship. That can be effective. It can also create fragility. When customer access belongs to someone else, the intermediary often controls the economics. Customer acquisition costs can rise. Terms can change. Data can remain inaccessible. The company may have little ability to move customers into adjacent products or services. This does not mean a company must own every channel. It means management should understand which parts of customer access can become durable. The distinction is between renting reach and building an asset. TRUST CAN BE PART OF DISTRIBUTION In health, distribution is not purely logistical. It is also about credibility. A pharmacy channel communicates something different from a social advertisement. A healthcare professional can provide legitimacy that a direct-response campaign cannot. A specialist community can create trust before a transaction occurs. A strong physical health location can become a distribution platform because people already have a reason to enter it. This means the route to market can carry both commercial access and trust. That combination is particularly powerful. The company that owns a credible relationship may be able to introduce additional products with less friction than a company beginning from zero each time. In that sense, trust itself can become distribution infrastructure. COMMERCIAL RIGHTS CAN CREATE OWNERSHIP-LIKE ECONOMICS Not every attractive economic position requires owning an entire company. Sometimes value sits in rights. Exclusive distribution rights. Territorial commercial rights. Licensing rights. Brand rights. Long-term supply arrangements. Joint commercialization structures. These arrangements can create durable participation in a market without requiring KØDE to own the underlying intellectual property or operating company outright. But the quality of the right matters. A nominal exclusivity that can be cancelled easily may have little strategic value. A commercial right becomes more meaningful when it combines duration, defensibility, economic participation and a route to customer access that can actually be built. This is why KØDE treats Commercial Rights as one possible ownership family rather than merely a contract category. The question is economic substance. WHAT CAN BE OWNED? Route-to-market strategy creates several possible ownership assets. A CUSTOMER RELATIONSHIP The company becomes the trusted point through which customers repeatedly engage. A DISTRIBUTION NETWORK The company controls access to a fragmented set of customers, professionals or institutions. A TERRITORY The company holds durable rights to commercialize a product in a defined geography. A CHANNEL POSITION The company develops privileged access inside a channel that is difficult to reproduce. A COMMERCIAL SYSTEM The processes, data, relationships and capabilities required to turn demand into repeatable revenue become transferable. A BRAND Trust and recognition reduce friction across multiple products or services. A PLACE A physical destination can itself become the route through which several health services or products reach customers. These assets can exist separately. The stronger opportunities often combine several. DACH MARKET ENTRY SHOWS WHY THIS MATTERS International health companies frequently look at Germany, Austria and Switzerland as one commercial opportunity. The reality is more fragmented. Language may be shared, but regulation, reimbursement, retail structure, professional relationships, pricing and customer behaviour can differ. A company can have a strong product and still fail because it enters through the wrong commercial architecture. This is why market entry is not simply localisation. It is route-to-market formation. Who should hold the rights? Which country should come first? Direct sales or distributor? Retail or professional channel? Own entity or commercial partner? How much local capability is required? Which relationships need to be built before scale? These decisions can determine whether the market becomes an asset or a recurring cost centre. DISTRIBUTION CAN PRECEDE COMPANY BUILDING Sometimes the route to market exists before the company. A specialist operator may control access to a category. A distributor may identify an underserved customer base. A property platform may have physical access to health consumers. A professional network may have trust but no dedicated commercial vehicle. A strategic right may become available for a product that lacks local market infrastructure. In these situations, the distribution position itself can justify company formation. The sequence can be: secure access, validate demand, build the commercial system, form a company around the opportunity, and create ownership around the resulting asset. This is different from starting with a product and then searching for customers. It starts with the market position. THE BEST ROUTES CREATE LEARNING A strong route to market does more than generate revenue. It generates information. Which customers convert? Why do they buy? Which products create repeat behaviour? Where does trust come from? Which price points work? Which channels produce better retention? Where do customers need education? What adjacent needs appear? This feedback can improve the company. Over time, the route to market can influence product development, service design, pricing and category expansion. That creates a compounding loop. Distribution produces data. Data improves the offer. A better offer strengthens the customer relationship. The relationship makes distribution more efficient. This is one reason route-to-market assets can become more valuable with duration. WHAT MAKES A ROUTE TO MARKET OWNABLE? Not every distribution arrangement deserves long-term ownership. KØDE looks for several characteristics. DURABILITY Can the commercial position survive beyond one campaign, one buyer or one contract cycle? CONTROL Does the company control enough of the customer relationship to build an asset? ECONOMICS Does the route support attractive contribution economics after all acquisition and channel costs? TRUST Does the route carry credibility, not merely reach? DATA Does the company learn from the customer relationship? EXPANSION Can the position support additional products, services, geographies or customer groups? DEFENSIBILITY Why would another company struggle to reproduce the same access? OWNERSHIP FIT Is there a reason for KØDE to own the commercial position rather than simply advise on it? The strongest opportunities pass several of these tests at once. ROUTE TO MARKET CAN CHANGE WHAT THE COMPANY IS A company that sells one product through a distributor is a product company. A company that owns a trusted customer relationship and can repeatedly bring relevant health products or services to that customer may become something else. It can become a commercial platform. A category company. A market-entry operator. A multi-brand system. A health destination. The strategic shift occurs when distribution stops being a downstream function and becomes part of the company's identity. That is where ownership becomes interesting. THE KØDE THESIS Health and life sciences contain enormous technical and scientific capability. Commercial capability is often less developed. Products are created before routes to market. Markets are selected before access is understood. Distribution is outsourced without considering what economic position is being surrendered. KØDE sees an opportunity in reversing that sequence. Understand the customer. Understand access. Understand trust. Understand the channel economics. Then decide what should be built, backed or owned around that position. The route to market is not always the most visible asset. But in many health businesses it determines whether every other asset can become economically valuable. That is why we treat it as more than sales. We treat it as something that can be built—and, in the right circumstances, something worth owning.